{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:13:13Z","timestamp":1786975993763,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd006881","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000}}],"reference-count":79,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006881.pub2","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T03:30:22Z","timestamp":1412911822000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Androgens for the anaemia of chronic kidney disease in adults"],"prefix":"10.1002","volume":"2014","author":[{"given":"Qianchun","family":"Yang","sequence":"first","affiliation":[{"name":"Ewha Woman's University; Graduate School of Pharmaceutical Sciences, College of Pharmacy; 52 Ewhayeodae-gil, Seodaemun-gu Seoul Korea, South 120-750"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minawaer","family":"Abudou","sequence":"additional","affiliation":[{"name":"Xinjiang Medical University; The Eye Department of the First Affiliated Hospital; Xinjiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi Sheng","family":"Xie","sequence":"additional","affiliation":[{"name":"Second Clinical Hospital of North Sichuan Medical College (Nanchong Central Hospital); Department of Nephrology; No. 97, Ren Min Nan Lu Nanchong Sichuan China 637007"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taixiang","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD006881.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.5414\/CPP48803","article-title":"The efficacy of oxymetholone in combination with erythropoietin on hematologic parameters and muscle mass in CAPD patients","volume":"48","author":"Aramwit","year":"2010","journal-title":"International Journal of Clinical Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0002|cit2","first-page":"461A","article-title":"Short course oral androgenic steroid improved lean body mass in continuous ambulatory peritoneal dialysis patients [abstract no: F-PO580]","volume":"16","author":"Supasyndh","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0003|cit3","first-page":"465A","article-title":"Oral androgenic steroid therapy for anemia in continuous ambulatory peritoneal dialysis patients [abstract no: F-PO599]","volume":"16","author":"Wiwatniwong","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD006881.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ki.1977.134","article-title":"A controlled trial of nandrolone decanoate in the treatment of uremic anemia","volume":"12","author":"Cattran","year":"1977","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD006881.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0272-6386(97)90307-3","article-title":"A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients","volume":"30","author":"Gaughan","year":"1997","journal-title":"American Journal of Kidney Diseases"},{"issue":"9","key":"10.1002\/14651858.CD006881.pub2-BIB0006|cit6","first-page":"1490","article-title":"A six month study of low-dose recombinant human erythropoietin alone and in combination with androgen for the treatment of anemia in chronic hemodialysis patients [abstract no: A1206]","volume":"7","author":"Liss","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD006881.pub2-BIB0007|cit7","first-page":"287A","article-title":"Effects of low-dose nandrolone decanoate on anemia and nutritional parameters in chronic hemodialysis patients with low-dose subcutaneous erythropoietin [abstract no: A1452]","volume":"10","author":"Kim","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0008|cit8","unstructured":"Koronis C Makris F Stavroulaki E Lambropoulou A Orthopoulos V Combination of low-dose recombinant human erythropoietin with androgens for the treatment of anaemia in hemodialysis patients [abstract] 37th Congress European Renal Association. European Dialysis and Transplantation Association; 2000 Sept 17-20; Nice, France 2000 235"},{"issue":"4","key":"10.1002\/14651858.CD006881.pub2-BIB0009|cit9","first-page":"715","article-title":"Effects of androgen therapy on hematologic and nutritional parameters in elderly peritoneal dialysis patients [abstract]","volume":"33","author":"Navarro","year":"2001","journal-title":"International Urology & Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD006881.pub2-BIB0010|cit10","first-page":"436A","article-title":"Prospective comparison between rHuEPO and androgens in CAPD patients: impact on hematologic and nutritional parameters [abstract]","volume":"12","author":"Navarro","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD006881.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1046\/j.1523-1755.2002.00271.x","article-title":"Randomized prospective comparison between erythropoietin and androgens in CAPD patients","volume":"61","author":"Navarro","year":"2002","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD006881.pub2-BIB0012|cit12","first-page":"c102-6","article-title":"Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis","volume":"99","author":"Sheashaa","year":"2005","journal-title":"Nephron"},{"issue":"1","key":"10.1002\/14651858.CD006881.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000205154","article-title":"Prospective controlled study of androgen effects on red cell oxygen transport and work capacity in chronic hemodialysis patients","volume":"83","author":"Hendler","year":"1990","journal-title":"Acta Haematologica"},{"issue":"1","key":"10.1002\/14651858.CD006881.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000205683","article-title":"Prospective controlled study of androgen therapy in the anemia of chronic renal disease: effects on iron kinetics","volume":"79","author":"Solomon","year":"1988","journal-title":"Acta Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD006881.pub2-BIB0015|cit15","first-page":"208","article-title":"Evaluation of efficacy of low dose recombinant human erythropoietin in combination with androgen therapy in anaemia of chronic renal failure","volume":"6","author":"Aggarwal","year":"2005","journal-title":"Journal, Indian Academy of Clinical Medicine"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0016|cit16","unstructured":"Aslanhan I Ersoy A Sarandol E Demiray M Usta M Dalkilic E The comparison of the effects of rHuEPO and testosterone ester compounds on lipid peroxidation in male hemodialysis patients [abstract] 38th Congress. European Renal Association. European Dialysis and Transplantation Association; 2001 Jun 24-27; Vienna, Austria 2001 212"},{"issue":"6","key":"10.1002\/14651858.CD006881.pub2-BIB0017|cit17","first-page":"A138","article-title":"The comparison of the effects of erythropoietin and testosterone ester compounds on lipid and lipoprotein profile in the male hemodialysis patients [abstract]","volume":"16","author":"Aslanhan","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD006881.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0272-6386(12)80246-0","article-title":"Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease","volume":"17","author":"Ballal","year":"1991","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006881.pub2-BIB0019|cit19","first-page":"264","article-title":"A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis","volume":"37","author":"Berns","year":"1992","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD006881.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.ajkd.2005.10.022","article-title":"Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease","volume":"47","author":"Brockenbrough","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006881.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000180834","article-title":"Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients","volume":"18","author":"Buchwald","year":"1977","journal-title":"Nephron"},{"issue":"2","key":"10.1002\/14651858.CD006881.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000190269","article-title":"Effects of erythropoietin on gonadotropin responses to gonadotropin-releasing hormone in uremic patients","volume":"77","author":"Diez","year":"1997","journal-title":"Nephron"},{"issue":"3","key":"10.1002\/14651858.CD006881.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.jrn.2007.01.001","article-title":"Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease","volume":"17","author":"Eiam-Ong","year":"2007","journal-title":"Journal of Renal Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD006881.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1008306301255","article-title":"Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis","volume":"9","author":"Gascon","year":"1999","journal-title":"Geriatric Nephrology & Urology"},{"issue":"20","key":"10.1002\/14651858.CD006881.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM197411142912002","article-title":"Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis","volume":"291","author":"Hendler","year":"1974","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006881.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3904\/kjim.2002.17.3.167","article-title":"Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin","volume":"17","author":"Lee","year":"2002","journal-title":"Korean Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0027|cit27","first-page":"485A","article-title":"Six months of testosterone replacement improves musculoskeletal health but not mental health or anemia management in men on hemodialysis [abstract no: F-PO690]","volume":"16","author":"Logan","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00002480-197902500-00086","article-title":"Controlled evaluation of hemodialysis patients on nandrolone decanoate (ND) vs testosterone enanthate (TE) (Androgens and dialysis patient)","volume":"25","author":"Mirahmadi","year":"1979","journal-title":"Transactions - American Society for Artificial Internal Organs"},{"issue":"6","key":"10.1002\/14651858.CD006881.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/089686080102100613","article-title":"Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients","volume":"21","author":"Mora","year":"2001","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0030|cit30","first-page":"136","article-title":"Androgen trial in renal anaemia","volume":"15","author":"Naik","year":"1978","journal-title":"Proceedings of the European Dialysis & Transplant Association"},{"issue":"15","key":"10.1002\/14651858.CD006881.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM198104093041504","article-title":"A comparison of androgens for anemia in patients on hemodialysis","volume":"304","author":"Neff","year":"1981","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006881.pub2-BIB0032|cit32","first-page":"S310","article-title":"Effect of nandrolone decanoate on response to low dose erythropoietin (EPO) in anemia of end stage renal disease (ESRD) patients on maintenance hemodialysis (MHD) [abstract]","volume":"3","author":"Saxena","year":"1997","journal-title":"Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD006881.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.1987.tb02269.x","article-title":"Androgen therapy in haemodialysis patients. II. Effects on red cell metabolism","volume":"65","author":"Solomon","year":"1987","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD006881.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.1988.tb02390.x","article-title":"Androgen therapy in haemodialysis patients: further observations on erythropoiesis and ferrokinetics","volume":"69","author":"Solomon","year":"1988","journal-title":"British Journal of Haematology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD006881.pub2-BIB0035|cit35","first-page":"58a","article-title":"Androgen therapy in hemodialysis patients: effects on red cell metabolism and exercise tolerance [abstract: 10]","volume":"68","author":"Solomon","year":"1986","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD006881.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000180751","article-title":"Response to parenteral iron with and without androgen therapy in patients undergoing regular haemodialysis","volume":"17","author":"Hartitzsch","year":"1976","journal-title":"Nephron"},{"issue":"2","key":"10.1002\/14651858.CD006881.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archinte.1974.00320200099013","article-title":"Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study","volume":"134","author":"Williams","year":"1974","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006881.pub2-BIB0038|cit38","first-page":"692","article-title":"A comparative study of nandrolone decanoate and erythropoietin on albumin levels, quality of life, and progression of renal disease in Indian predialysis CKD patients [abstract no: W455]","volume":"18","author":"Ganguli","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Dec","key":"10.1002\/14651858.CD006881.pub2-BIB0039|cit39","first-page":"1188","article-title":"Nandrolone decanoate is equiefacious to erythropoietin in correcting anemia and quality of life in predialysis chronic kidney disease patients [abstract no: 137]","volume":"51","author":"Ganguli","year":"2003","journal-title":"Journal of the Association of Physicians of India"},{"issue":"Dec","key":"10.1002\/14651858.CD006881.pub2-BIB0040|cit40","first-page":"1188","article-title":"Long term effects of anemia correction on progression of renal disease and cognitive function using erythropoietin and androgenic steroids [abstract no: 136]","volume":"51","author":"Singh","year":"2003","journal-title":"Journal of the Association of Physicians of India"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006881.pub2-BIB0041|cit41","first-page":"692","article-title":"A comparative study of nandrolone decanoate versus recombinant human erythropoietin on anemia in Indian predialysis chronic kidney disease patients [abstract no: W456]","volume":"18","author":"Singh","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0042|cit42","first-page":"827","article-title":"Effects of Org DD-100 (Nandrolone decanoate) on renal anemia: a multi-center double-blind study","volume":"14","author":"Ota","year":"1986","journal-title":"Rinsho Hyoka"},{"issue":"2","key":"10.1002\/14651858.CD006881.pub2-BIB0043|cit43","first-page":"349","article-title":"High dose nandrolone decanoate therapy on the anemia of haemodialysis patients [abstract]","volume":"28","author":"Ota","year":"1985","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD006881.pub2-BIB0044|cit44","first-page":"2473","article-title":"Therapeutic efficacy of nandrolone decanoate for anemia in hemodialysis patients: a multicenter randomized dose-finding study comparing 3 dose regimens","volume":"20","author":"Suzuki","year":"1986","journal-title":"Kiso to Rinsho"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Adamu B Ma'aji SM Erwin PJ Tleyjeh IM Meta-analysis of randomized controlled trials on androgens versus erythropoietin for anaemia of chronic kidney disease: Implications for developing countries. International Journal of Nephrology, 2012 http:\/\/www.hindawi.com\/journals\/ijn\/2012\/580437\/ 10.1155\/2012\/580437","DOI":"10.1155\/2012\/580437"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0046|cit46","unstructured":"Britannica Online Encyclopaedia Androgens http:\/\/www.britannica.com\/eb\/article-292\/androgen"},{"issue":"25","key":"10.1002\/14651858.CD006881.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","article-title":"Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study","volume":"23","author":"Leyland-Jones","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006881.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003266.pub2","article-title":"Recombinant human erythropoietin for chronic renal failure in pre-dialysis patients","author":"Cody","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD006881.pub2-BIB0049|cit49","first-page":"379","article-title":"Dialysis Outcomes and Practice Patterns Study: data on the use of central venous catheters in chronic hemodialysis","volume":"22","author":"Combe","year":"2001","journal-title":"Nephrologie"},{"issue":"18","key":"10.1002\/14651858.CD006881.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2003.12.121","article-title":"Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?","volume":"21","author":"Efficace","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD006881.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jclinepi.2006.03.006","article-title":"Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology","volume":"59","author":"Efficace","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD006881.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdl494","article-title":"Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making","volume":"18","author":"Efficace","year":"2007","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006881.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.1989.18","article-title":"The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin","volume":"35","author":"Eschbach","year":"1989","journal-title":"Kidney International"},{"issue":"9","key":"10.1002\/14651858.CD006881.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1093\/ndt\/gfl111","article-title":"The European Best Practice Guidelines (EBPG) for peritoneal dialysis recommendation for minimum Kt\/Vurea is not supported by current evidence","volume":"21","author":"Geddes","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9392","key":"10.1002\/14651858.CD006881.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"issue":"7174","key":"10.1002\/14651858.CD006881.pub2-BIB0056|cit56","first-page":"227","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0057|cit57","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD006881.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1681\/ASN.V132504","article-title":"Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey","volume":"13","author":"Hsu","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"22","key":"10.1002\/14651858.CD006881.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1073\/pnas.82.22.7580","article-title":"Cloning and expression of the human erythropoietin gene","volume":"82","author":"Lin","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0060|cit60","first-page":"ii1","article-title":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure","volume":"19 Suppl 2","author":"Locatelli","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD006881.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD006881.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease","volume":"20","author":"McClellan","year":"2004","journal-title":"Current Medical Research & Opinion"},{"issue":"4","key":"10.1002\/14651858.CD006881.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/A:1014491110361","article-title":"Androgen therapy for anemia in elderly uremic patients","volume":"32","author":"Navarro","year":"2001","journal-title":"International Urology & Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD006881.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/089686080102100104","article-title":"Effect of androgens on anemia and malnutrition in renal failure: implications for patients on peritoneal dialysis","volume":"21","author":"Navarro","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"11","key":"10.1002\/14651858.CD006881.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/ndt\/gfg370","article-title":"In the erythropoietin era, can we forget alternative or adjunctive therapies for renal anaemia management? The androgen example","volume":"18","author":"Navarro","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD006881.pub2-BIB0066|cit66","first-page":"S1","article-title":"K\/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0067|cit67","unstructured":"National Kidney Foundation Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease http:\/\/www.kidney.org\/Professionals\/kdoqi\/guidelines_anemia\/index.htm"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0068|cit68","unstructured":"National Kidney Foundation About chronic kidney disease http:\/\/www.kidney.org\/kidneydisease\/aboutckd.cfm"},{"issue":"10","key":"10.1002\/14651858.CD006881.pub2-BIB0069|cit69","first-page":"873","article-title":"Selective androgen receptor modulators: in pursuit of tissue-selective androgens","volume":"7","author":"Omwancha","year":"2006","journal-title":"Current Opinion in Investigational Drugs"},{"issue":"3","key":"10.1002\/14651858.CD006881.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/en.2005-1029","article-title":"Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback","volume":"147","author":"Pielecka","year":"2006","journal-title":"Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD006881.pub2-BIB0071|cit71","first-page":"220","article-title":"Epoetin-induced pure red cell aplasia successfully treated with androgens","volume":"19","author":"Sanchez de la Nieta","year":"2006","journal-title":"Journal of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD006881.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF03345745","article-title":"Androgens and erythropoiesis: past and present","volume":"32","author":"Shahani","year":"2009","journal-title":"Journal of Endocrinological Investigation"},{"issue":"1","key":"10.1002\/14651858.CD006881.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1681\/ASN.V71140","article-title":"Androgen versuserythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study","volume":"7","author":"Teruel","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD006881.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/00365599609181318","article-title":"Androgen therapy for anaemia of chronic renal failure","volume":"30","author":"Teruel","year":"1996","journal-title":"Scandinavian Journal of Urology & Nephrology"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0075|cit75","unstructured":"United States Renal Data System Atlas of end-stage renal disease in the United States hthttp:\/\/www.usrds.org\/atlas06.aspx"},{"key":"10.1002\/14651858.CD006881.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000168217","article-title":"Implications of recombinant erythropoietin therapy for renal transplantation","volume":"10 Suppl 2","author":"Ward","year":"1990","journal-title":"American Journal of Nephrology"},{"issue":"8517","key":"10.1002\/14651858.CD006881.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(86)92192-6","article-title":"Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis","volume":"2","author":"Winearls","year":"1986","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD006881.pub2-BIB0078|cit78","first-page":"633A","article-title":"Mechanisms of action of androgen treatment on the anemia of experimental chronic renal failure [abstract]","volume":"Program & Abstr","author":"Yared","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD006881.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006881","article-title":"Androgens for the anaemia of chronic kidney disease in adults","author":"Tang","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006881.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T23:34:27Z","timestamp":1696116867000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006881.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":79,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006881.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.720889179.793501161","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]}}}